NANGIBOTIDE
UNII 59HD7BLX9H

Substance Identification & Data

This profile provides standardized clinical and technical data for Nangibotide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 59HD7BLX9H.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2014384-91-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

59HD7BLX9H

CAS Registry Number

2014384-91-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NANGIBOTIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C166834

National Cancer Institute reference terminology for clinical and research data.

INN ID

10637

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Nangibotide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

NANGIBOTIDE

Common Names & Synonyms

NANGIBOTIDE [INN]

NANGIBOTIDE [WHO-DD]

Brand / Trade Names

MOTREM

Systematic Nomenclature

LEU-GLN-GLU-GLU-ASP-ALA-GLY-GLU-TYR-GLY-CYS-MET-NH2

SYS

L-METHIONINAMIDE, L-LEUCYL-L-GLUTAMINYL-L-.ALPHA.-GLUTAMYL-L-.ALPHA.-GLUTAMYL-L-.ALPHA.-ASPARTYL-L-ALANYLGLYCYL-L-.ALPHA.-GLUTAMYL-L-TYROSYLGLYCYL-L-CYSTEINYL-

SYS